Rowland Thomas Andrew
- SEC CIK
- 0001507496
In the past year, 2 open-market sale filings worth $393.8K and no purchases.
Current role at each company
- ANIP Ani Pharmaceuticals IncSVP, HEAD - ESTABLISHED BRANDSas of May 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $393.8K
- 2 filings
- Net
- −$393.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Rowland Thomas Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 (view filing) | May 12 | 1 day | Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS | SSale | −459 | $79.21 | −$36.4K | −1.2%38.3K after | |
| Mar 13, 2026 (view filing) | Mar 11 | 2 days | Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS | SSale | −4.77K | $74.91 | −$357.5K | −11.0%38.7K after | |
| Aug 14, 2025 (view filing) | Aug 12 | 2 days | Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS | SSale | −4.97K | $85.71 | −$426.4K | −10.9%40.8K after |